To identify cellular localization of BCYRN1, RT-qPCR analysis of nuclear and cytoplasmic RNAs was carried out to show that BCYRN1 was preferentially located in the cytoplasm (Fig. 1f), consistent with the subcellular fractionation in other cancer types [29–31]. The gene discussed is BCYRN1; the disease is cancer.